LFVN Lifevantage

LifeVantage to Participate in Upcoming Investor Conferences

LifeVantage to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Aug. 27, 2020 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that Darren Jensen, the Company's President and Chief Executive Officer and Steve Fife, Chief Financial Officer, will participate in two upcoming investor conferences virtually.  These include the LD Micro 500, to be held September 1-4, 2020 and the H.C. Wainwright 22nd Annual Global Investment Conference to be held September 14-16.

At the LD Micro 500, Mr. Jensen and Mr. Fife will meet with investors and participate in a virtual presentation at 9:20 a.m. Mountain Time (11:20 a.m. Eastern Time) on Wednesday, September 2, 2020. The webcast of their presentation will be available on the Investor Relations – Events and Presentations section of the Company's website at or directly at . The webcast will be archived for approximately 30 days.

At the H.C. Wainwright 22nd Annual Global Investment Conference, Mr. Jensen and Mr. Fife will meet with investors and participate in a virtual presentation on Tuesday, September 15, 2020.

The slide presentation to be referenced at the conferences will be available on the Investor Relations – Events and Presentations section of the Company's website at .

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product line, LifeVantage® Omega+ and ProBio dietary supplements, the TrueScience® line of Nrf2 infused skin care and hair care products, Petandim® for Dogs, Axio® smart energy drink mixes, and the PhysIQ™ weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit .

Investor Relations Contact:

Scott Van Winkle

Managing Director, ICR

(617) 956-6736

EN
27/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Announces Closing of LoveBiome Acquisition

LifeVantage Announces Closing of LoveBiome Acquisition Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transa...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter ...

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fourth Quarter Fiscal 2025 Summary*: Revenue of $55.1 million, an increase of 12.6% from the prior year period. Excluding the impact of foreign currency fluctuations, fourth quarter r...

 PRESS RELEASE

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership i...

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company...

 PRESS RELEASE

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global I...

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY. Mr. Fife and Mr. Aure will meet with investors and...

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid September 16, 2025 to all stockholders of record at the close of business on September 8, 2025. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch